» Authors » Masanori Minagawa

Masanori Minagawa

Explore the profile of Masanori Minagawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 596
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Takatani R, Kubota T, Minagawa M, Inoue D, Fukumoto S, Ozono K, et al.
J Epidemiol . 2022 Sep; 33(11):569-573. PMID: 36123043
Background: Pseudohypoparathyroidism (PHP) and nonsurgical hypoparathyroidism (NS-HypoPT) are rare diseases with hypocalcemia, hyperphosphatemia, and high and low parathyroid hormone levels, respectively. In Japan, over 20 years have passed since the...
2.
Shimazaki S, Kazukawa I, Minagawa M
Clin Pediatr Endocrinol . 2022 Apr; 31(2):54-58. PMID: 35431444
Thyroid dysfunction has been observed in childhood cancer survivors (CCSs) who have undergone hematopoietic stem cell transplantation (HSCT). We retrospectively analyzed the thyroid function of 54 CCSs who underwent HSCT...
3.
Shimazaki S, Kazukawa I, Yamammoto H, Mori K, Kihara M, Naruke Y, et al.
CEN Case Rep . 2021 Jul; 11(1):50-54. PMID: 34296353
Fibroblast growth factor 23 (FGF-23), a hormone mainly secreted by osteocytes and osteoblasts, regulates phosphate and vitamin D levels. However, the in vivo significance of FGF-23 is not fully elucidated....
4.
Ito N, Kubota T, Kitanaka S, Fujiwara I, Adachi M, Takeuchi Y, et al.
J Bone Miner Metab . 2021 Jul; 39(6):1066-1075. PMID: 34255195
Introduction: Measurement of fibroblast growth factor 23 (FGF23) has been reported to be clinically useful for the differential diagnosis of chronic hypophosphatemia. However, assays for research use only are available...
5.
Shimazaki S, Kazukawa I, Mori K, Kihara M, Minagawa M
Endocrinol Diabetes Metab Case Rep . 2021 Apr; 2021. PMID: 33865236
Summary: Ammonium acid urate (AAU) crystals are rare in industrialized countries. Furthermore, the number of children with diabetic ketoacidosis (DKA) who develop severe acute kidney injury (AKI) after hospitalization is...
6.
Shimazaki S, Kazukawa I, Mori K, Kihara M, Minagawa M
Endocr J . 2019 Oct; 67(2):131-140. PMID: 31656261
We retrospectively analyzed endocrine late effects in 81 childhood cancer survivor (CCS) patients who had been referred to our endocrinology department in Chiba Children's Hospital between January 1, 2008 and...
7.
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, et al.
Nat Rev Endocrinol . 2018 Jul; 14(8):476-500. PMID: 29959430
This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short...
8.
Shimazaki S, Kazukawa I, Ishida M, Minagawa M
Clin Pediatr Endocrinol . 2018 Apr; 27(2):75-79. PMID: 29662266
Thyroid nodules have been observed in childhood cancer survivors (CCS) treated with chemotherapy and radiotherapy. We report four patients with thyroid nodules identified during the long-term follow-up of children who...
9.
Minagawa M
Clin Calcium . 2017 Oct; 27(11):1623-1628. PMID: 29074836
The patients with hypoparathyroidism have been treated with active vitamin D(ie, alfacalcidol and calcitriol). Parathyroid hormone(PTH)increases extracellular calcium concentration partly through the activation of vitamin D, and active vitamin D...
10.
Yorifuji T, Horikawa R, Hasegawa T, Adachi M, Soneda S, Minagawa M, et al.
Clin Pediatr Endocrinol . 2017 Aug; 26(3):127-152. PMID: 28804205
Congenital hyperinsulinism is a rare condition, and following recent advances in diagnosis and treatment, it was considered necessary to formulate evidence-based clinical practice guidelines reflecting the most recent progress, to...